ANASTASIA LAPIKAS: Open Payments
NPI 1811376320 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 50 payments from 17 companies in 2025. Trend: 2023 $1,405 · 2024 $1,794 · 2025 $1,116
Food & beverage: $961Education: $155
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $179 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| GENZYME CORPORATION | 3 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Amgen Inc. | 5 | $78 |
| GlaxoSmithKline, LLC. | 1 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 1 | $56 |
| Vifor Pharma, Inc. | 3 | $49 |
Products named: DUPIXENT, Kerendia, JYNARQUE, JARDIANCE, FARXIGA, Veltassa, TARPEYO, Korlym.
Industry payments across OH — which companies pay providers there.
